Diktat Verrat Stereotyp tumor markeri he4 Beschäftigung Die Datenbank Künstlich
HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases | Journal of Ovarian Research | Full Text
Clinical analysis of four serum tumor markers in 458 patients with ova | CMAR
SciELO - Brasil - A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses A comparison of CA125, HE4, risk ovarian
PDF] Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo | Semantic Scholar
Calibrators for HE4 and HER2 Tumor Marker Assays - Clinical Lab Products
Marker levels of the adnexal masses 95% CI | Download Table
Ovarian Cancer | AACC.org
PDF] Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo | Semantic Scholar
Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response | Diagnostic Pathology | Full Text
Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download
Which Tumor Marker Can Be Used to Assess Stage, Prognosis, Response to Treatment? | ONS Voice
Serum CA125, HE4 and ROMA levels according to histology, FIGO stage and... | Download Table
Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer? | Bentham Science
IVD Antibody Development Services for HE4 Marker - Creative Biolabs
PDF] HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | Semantic Scholar
Human Epididymis Protein 4 (HE4) Is a Secreted Glycoprotein that Is Overexpressed by Serous and Endometrioid Ovarian Carcinomas | Cancer Research
Serum human epididymis protein 4 (HE4) as a tumor marker in men with lung cancer
The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer
The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes | Scientific Reports
Reference ranges of HE4 and CA125 according to age group | Download Table
HE4, A New Potential Tumor Marker for Early Diagnosis and Predicting of Breast Cancer Progression
InteliQ Tumor Marker Control | Bio-Rad Laboratories
Frontiers | Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer | Oncology
HE4 is an independent prognostic marker in endometrial cancer patients - Gynecologic Oncology
Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses - American Journal of Obstetrics & Gynecology
Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125 - Gynecologic Oncology